Although edited for clarity, it should not be considered an exact replication of the podcast and may also be updated as needed
market as of April 2026, because active patents keep branded products in place
Side effects may increase but remain manageable for most
We encourage patients to consult with our experienced healthcare providers to explore how Semaglutide GLP-1, alongside lifestyle changes, can be part of an effective strategy for achieving and maintaining a healthy weight
About this article Cite this article Gonzales-Uribe, A., Ruiz-Cortez, R., Collantes-Silva, N
There is no clinical trial data on split-dose retatrutide safety